Hannah Valantine - 23 Oct 2021 Form 3 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role: Director
Signature: /s/ Barbara Bispham, Attorney-in-Fact
Issuer symbol: BBIO
Transactions as of: 23 Oct 2021
Net transactions value: $0
Form type: 3
Filing time: 26 Oct 2021, 21:14:09 UTC
Previous filing: 04 Oct 2021
Next filing: 26 Oct 2021
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney